1 minute read
MEDICAL ONCOLOGY
CLOSED TO RECRUITMENT — AUSTRALIA
Abbrev. Title
I3Y-MC-JPCP
Protocol Title
An Open-Label, Randomized Phase 2 Study of the Impact of Food On Tolerability When Receiving Abemaciclib for Patients with Previously Treated Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer
IBCSG 24-02 BIG 2-02 SOFT
A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Post Menopausal Women with Endocrine Responsive Breast Cancer
ICON9
An International Phase III Randomised Trial of Cediranib & Olaparib Maintenance in Patients with Relapse Platinum Sensitive Ovarian Cancer
IMGN853-0417 SORAYA
A Phase 3, Single Arm Study of Mirvetuximab Soravtansine in Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression
IMMU-132-13 Tropics-04
A Randomized Open-Label Phase III Study of Sacituzumab Govitecan versus Treatment of Physician’S Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer
IMMU-132-13 Tropics-04
A Randomized Open-Label Phase III Study of Sacituzumab Govitecan versus Treatment of Physician’s Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer
IMMU-132-13 Tropics-04
A Randomized Open-Label Phase III Study of Sacituzumab Govitecan versus Treatment of Physician’S Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer
INMB-001
Phase 1 Open-Label, Dose Escalation Study of INB03 in Patients with Metastatic Cancer with Increased Inflammatory Biomarkers in Peripheral Blood
IRFMN-EN-7556 ATTEND Phase 3 Double-blind Randomized Placebo Controlled Trial of Atezolizumab in Combination with Paclitaxel and Carboplatin in Women with Advanced/Recurrent Endometrial Cancer
J2J-MC-JZLA EMBER A Phase 1a/1b Study of LY3484356 Administered as Monotherapy and in Combination with Anticancer Therapies for Patients with ER+ Locally Advanced or Metastatic Breast Cancer and Other Select Non-Breast Cancers
